$LXEO Cashflow Statement | Understand Stock

$LXEO

$2.87 +$0.17 (6.3%) Close

$LXEO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Reduction in the carrying amount of ROU assets, operating
Reduction in the carrying amount of ROU assets, finance
Stock based compensation expense
Depreciation and amortization expense
Non-cash gain on long-term investment
Net realized gain on investments in U.S. Treasury securities
Amortization of premium (accretion of discount) on investments in U.S. Treasury securities
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Accounts payable
Accrued expenses and other current liabilities
Taxes payable
Lease liabilities, operating
Lease liabilities, finance
Change in fair value of convertible SAFE Note liability
Net cash used in operating activities
Cash flows from investing activities:
Purchase of internal use software
Purchase of property and equipment
Purchases of investments
Proceeds from sales or maturities of investments
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from exercise of stock options
Payments on finance leases
Treasury stock repurchases
Payments of issuance costs on convertible SAFE Note
Proceeds from issuance of convertible SAFE Note
Payment of financing and stock issuance costs
Proceeds from issuance of common stock, pre-funded warrants and warrants to purchase common stock upon May 2025 Private Placement
Proceeds from issuance of common stock and pre-funded warrants to purchase common stock upon October 2025 Financing Transactions
Third-party commissions and offering costs incurred upon October 2025 Financing Transactions
Net cash provided by financing activities
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash and cash equivalents at beginning of period
Restricted cash included in long-term assets at beginning of period
Cash and cash equivalents at end of period
Restricted cash included in long-term assets at end of period
Supplemental disclosures of cash flow information
Interest paid
Supplemental disclosure of non-cash activities
Deferred financing costs included in accounts payable and accrued expenses
Deferred offering costs included in accounts payable and accrued expenses
Unrealized loss on investments
Reclassification of internal use software into prepaid expenses
Issuance costs related to convertible debt included in accounts payable and accrued expenses
(Property and equipment purchased in the prior period and paid in the current period), net of property and equipment purchased in the current period included in accounts payable
Finance lease right-of use assets and finance lease liabilities recognized
Conversion of convertible preferred stock into common stock in connection with initial public offering, net of issuance costs
Conversion of SAFE Note into common stock in connection with initial public offering, net of issuance costs
Amounts reclassified from deposit liabilities upon the vesting of early-exercised stock options previously subject to repurchase, net of proceeds received from early exercise of unvested stock options subject to repurchase and recorded as deposit liabilities
Unpaid offering costs included in accounts payable and accrued expenses

Comments